Literature DB >> 26855337

A CHALLENGING CASE OF SEVERE INFANTILE CHOLESTASIS IN ALPHA-1 ANTITRYPSIN DEFICIENCY.

Zahida Khan1, Veena L Venkat2, Kyle A Soltys3, Donna B Stolz4, Sarangarajan Ranganathan5.   

Abstract

Jaundice in the newborn period can be physiologic and is often due to benign causes. Jaundice due to conjugated hyperbilirubinemia extending beyond the second week of life may be an early sign of several cholestatic or metabolic liver diseases, and it requires logical and timely analysis so that specific treatments can be initiated. A1AT deficiency is the most common genetic cause of pediatric liver disease and transplantation, and it must be considered when evaluating cholestatic infants. Here, we present an unusual case of A1AT deficiency with severe infantile cholestasis and rapid decompensation in the first 4 months of life, where in-depth but timely diagnosis was crucial for the appropriate intervention to take place.

Year:  2016        PMID: 26855337     DOI: 10.2350/15-09-1711-CR.1

Source DB:  PubMed          Journal:  Pediatr Dev Pathol        ISSN: 1093-5266


  15 in total

1.  Misdiagnosis of α-1 antitrypsin phenotype in an infant with CMV infection and liver failure.

Authors:  Patricio Arias; John Kerner; Megan Christofferson; William Berquist; K T Park
Journal:  Dig Dis Sci       Date:  2014-08       Impact factor: 3.199

2.  Pathology and pathogenesis of liver disease in alpha-1-antitrypsin deficient individuals.

Authors:  O Aagenaes; M TFagerhol; K Elgjo; E Munthe; T Hovig
Journal:  Postgrad Med J       Date:  1974-06       Impact factor: 2.401

3.  Stool color card screening for early detection of biliary atresia and long-term native liver survival: a 19-year cohort study in Japan.

Authors:  Yan-Hong Gu; Koji Yokoyama; Koichi Mizuta; Takashi Tsuchioka; Toyoichiro Kudo; Hideyuki Sasaki; Masaki Nio; Julian Tang; Takayoshi Ohkubo; Akira Matsui
Journal:  J Pediatr       Date:  2015-02-11       Impact factor: 4.406

4.  Liver disease in alpha1-antitrypsin deficiency detected by screening of 200,000 infants.

Authors:  T Sveger
Journal:  N Engl J Med       Date:  1976-06-10       Impact factor: 91.245

5.  Alpha 1-antitrypsin deficiency and infantile liver disease.

Authors:  J L McPhie; S Binnie; P W Brunt
Journal:  Arch Dis Child       Date:  1976-08       Impact factor: 3.791

6.  Alpha1-antitrypsin deficiency in 26-year-old subjects: lung, liver, and protease/protease inhibitor studies.

Authors:  Eeva Piitulainen; Joyce Carlson; Kjell Ohlsson; Tomas Sveger
Journal:  Chest       Date:  2005-10       Impact factor: 9.410

7.  Impact of age at Kasai operation on its results in late childhood and adolescence: a rational basis for biliary atresia screening.

Authors:  Marie-Odile Serinet; Barbara E Wildhaber; Pierre Broué; Alain Lachaux; Jacques Sarles; Emmanuel Jacquemin; Frédéric Gauthier; Christophe Chardot
Journal:  Pediatrics       Date:  2009-05       Impact factor: 7.124

8.  Biliary atresia: the Canadian experience.

Authors:  Richard A Schreiber; Collin C Barker; Eve A Roberts; Steven R Martin; Fernando Alvarez; Lesley Smith; J Decker Butzner; Iwona Wrobel; David Mack; Stanley Moroz; Mohsin Rashid; Rabin Persad; Dominique Levesque; Herbert Brill; Garth Bruce; Jeff Critch
Journal:  J Pediatr       Date:  2007-10-22       Impact factor: 4.406

Review 9.  Mysteries of α1-antitrypsin deficiency: emerging therapeutic strategies for a challenging disease.

Authors:  Raafe Ghouse; Andrew Chu; Yan Wang; David H Perlmutter
Journal:  Dis Model Mech       Date:  2014-04       Impact factor: 5.758

10.  PoopMD, a Mobile Health Application, Accurately Identifies Infant Acholic Stools.

Authors:  Amy Franciscovich; Dhananjay Vaidya; Joe Doyle; Josh Bolinger; Montserrat Capdevila; Marcus Rice; Leslie Hancock; Tanya Mahr; Douglas B Mogul
Journal:  PLoS One       Date:  2015-07-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.